Not submitted to FDA: Ivabradine has been approved for marketing for patients with angina by several regulatory agencies throughout the world. The drug has never been submitted for review by the fda because the french manufacturer, servier, lacked an american subsidiary to market the drug. However in july 2013, amgen announced that it had obtained commercial rights in the U.S. To this novel oral drug for further tests.
Answered 1/24/2019
4.7k views
No FDA approval: It has not been approved by the fda.
Answered 10/24/2015
4.7k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question